ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
How to become rich with ASX shares over the next 10 years
Blue Chip Shares
The ASX 200 stocks I'd be happy to hold until retirement
How to invest
How I'd build a $1,000-a-month passive income from ASX shares
Growth Shares
5 incredible ASX growth stocks to buy for 2026
How to invest
How to turn small ASX share investments into life-changing money
Growth Shares
3 ASX 200 growth shares to buy and hold for 10 years
How to invest
How to make $20,000 of passive income from ASX shares
How to invest
How to retire with a $1 million ASX share portfolio
Growth Shares
The Australian stocks I'd trust for the next 10 years
Growth Shares
10 ASX shares I would buy in 2026
How to invest
My blueprint for monthly income starting with $40,000
Blue Chip Shares
The ASX blue chip shares I'd buy during the next correction
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
